{"id":"https://openalex.org/W2407569726","doi":"https://doi.org/10.1111/cas.12819","title":"2015 Guidance on cancer immunotherapy development in early\u2010phase clinical studies","display_name":"2015 Guidance on cancer immunotherapy development in early\u2010phase clinical studies","publication_year":2015,"publication_date":"2015-12-01","ids":{"openalex":"https://openalex.org/W2407569726","doi":"https://doi.org/10.1111/cas.12819","mag":"2407569726","pmid":"https://pubmed.ncbi.nlm.nih.gov/26767933","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4714668"},"language":"en","primary_location":{"id":"doi:10.1111/cas.12819","doi":"https://doi.org/10.1111/cas.12819","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cas.12819","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.12819","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.12819","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Working Group for Effector Cell Therapy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Working Group for Effector Cell Therapy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Working Group for Cancer Vaccines and Adjuvants","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Working Group for Cancer Vaccines and Adjuvants","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Working Group for Anti\u2010immune Checkpoint Therapy and Comprehensive Cancer Immunotherapy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Working Group for Anti\u2010immune Checkpoint Therapy and Comprehensive Cancer Immunotherapy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2600,"currency":"USD","value_usd":2600},"apc_paid":{"value":2600,"currency":"USD","value_usd":2600},"fwci":1.0708,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.79957914,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"106","issue":"12","first_page":"1761","last_page":"1771"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.021900000050663948,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.996999979019165},{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.8510000109672546},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.6790000200271606},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9369999766349792},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/regulatory-science","display_name":"regulatory science","score":0.8989999890327454},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.853855550289154},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.7323797345161438},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.7313417792320251},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6123365759849548},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5917983055114746},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5382847785949707},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5296537280082703},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.4526325762271881},{"id":"https://openalex.org/C2778378633","wikidata":"https://www.wikidata.org/wiki/Q2378309","display_name":"Cancer vaccine","level":4,"score":0.4448798894882202},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.43296951055526733},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4201241731643677},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34950870275497437},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15298369526863098}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D064987","descriptor_name":"Cell- and Tissue-Based Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/cas.12819","doi":"https://doi.org/10.1111/cas.12819","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cas.12819","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.12819","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4714668","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4714668","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Sci","raw_type":"Text"},{"id":"pmid:26767933","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26767933","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer science","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:00953:0006741386","doi":null,"is_oa":false,"landing_page_url":"https://teikyo-u.repo.nii.ac.jp/records/2026294","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Science","raw_type":"journal article"}],"best_oa_location":{"id":"doi:10.1111/cas.12819","doi":"https://doi.org/10.1111/cas.12819","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cas.12819","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.12819","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1079201407","display_name":"Analysis of elimination of non-self and development of Stealth T cells aiming generalized antigen-specific adoptive T cell therapy","funder_award_id":"15H04918","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G6922862753","display_name":"Investigation of differential immune status among cancer patients and development of personalized cancer therapy by combining immunomodulation","funder_award_id":"26221005","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2407569726.pdf","grobid_xml":"https://content.openalex.org/works/W2407569726.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W61400814","https://openalex.org/W139987191","https://openalex.org/W643010292","https://openalex.org/W1545036781","https://openalex.org/W1556099520","https://openalex.org/W1577847722","https://openalex.org/W1872420254","https://openalex.org/W1937410663","https://openalex.org/W1965231777","https://openalex.org/W1966107523","https://openalex.org/W1981528932","https://openalex.org/W1981553458","https://openalex.org/W1991701295","https://openalex.org/W1992699637","https://openalex.org/W1994815971","https://openalex.org/W2002662941","https://openalex.org/W2010121426","https://openalex.org/W2021472146","https://openalex.org/W2022996006","https://openalex.org/W2023068069","https://openalex.org/W2024852735","https://openalex.org/W2029884055","https://openalex.org/W2047901362","https://openalex.org/W2054857153","https://openalex.org/W2062398277","https://openalex.org/W2064510700","https://openalex.org/W2066671159","https://openalex.org/W2073310925","https://openalex.org/W2073863670","https://openalex.org/W2076948707","https://openalex.org/W2082830752","https://openalex.org/W2087057703","https://openalex.org/W2091828109","https://openalex.org/W2093914368","https://openalex.org/W2097166956","https://openalex.org/W2097995306","https://openalex.org/W2099570622","https://openalex.org/W2100158834","https://openalex.org/W2101653483","https://openalex.org/W2105135927","https://openalex.org/W2108706633","https://openalex.org/W2109653150","https://openalex.org/W2117108378","https://openalex.org/W2118599195","https://openalex.org/W2118982164","https://openalex.org/W2123363005","https://openalex.org/W2131642655","https://openalex.org/W2143163879","https://openalex.org/W2143381422","https://openalex.org/W2144872368","https://openalex.org/W2147621820","https://openalex.org/W2149752186","https://openalex.org/W2150145041","https://openalex.org/W2150817618","https://openalex.org/W2160834915","https://openalex.org/W2172170289","https://openalex.org/W2560367415","https://openalex.org/W2572174216"],"related_works":["https://openalex.org/W804995307","https://openalex.org/W2982641363","https://openalex.org/W1989625454","https://openalex.org/W7168359041","https://openalex.org/W2803975328","https://openalex.org/W2888777436","https://openalex.org/W4389639889","https://openalex.org/W2343109697","https://openalex.org/W3028523516","https://openalex.org/W7095082442"],"abstract_inverted_index":{"The":[0,102],"development":[1,135],"of":[2,11,16,25,36,58,60,79,104,119,136,143,156],"cancer":[3,84,100,121,137,149],"immunotherapies":[4,66],"is":[5],"progressing":[6],"rapidly":[7],"with":[8,67,123,140],"a":[9,80],"variety":[10],"technological":[12],"approaches.":[13],"They":[14],"consist":[15],"\"cancer":[17],"vaccines\",":[18],"which":[19,38],"are":[20,107],"based":[21],"on":[22],"the":[23,77,133,141],"idea":[24],"vaccination,":[26],"\"effector":[27],"cell":[28,152],"therapy\",":[29],"classified":[30],"as":[31],"passive":[32],"immunotherapy,":[33,122],"and":[34,64,70,110,129,154],"\"inhibition":[35],"immunosuppression\",":[37],"intends":[39],"to":[40,44,94,98,108,130,132],"break":[41],"immunological":[42],"tolerance":[43],"autoantigens":[45],"or":[46],"immunosuppressive":[47],"environments":[48],"characterizing":[49],"antitumor":[50],"immune":[51,61,159],"responses.":[52],"Recent":[53],"reports":[54],"showing":[55],"clinical":[56,117],"evidence":[57],"efficacy":[59],"checkpoint":[62,160],"inhibitors":[63],"adoptive":[65],"tumor-infiltrating":[68],"lymphocytes":[69],"tumor-specific":[71],"receptor":[72],"gene-modified":[73],"T":[74],"cells":[75],"indicate":[76],"beginning":[78],"new":[81],"era":[82],"for":[83],"immunotherapy.":[85,101],"This":[86,146],"guidance":[87,106,147],"summarizes":[88],"ideas":[89],"that":[90],"will":[91],"be":[92],"helpful":[93],"those":[95],"who":[96],"plan":[97],"develop":[99],"aims":[103],"this":[105,127],"discuss":[109],"offer":[111],"important":[112],"points":[113],"in":[114,126],"early":[115],"phase":[116],"studies":[118],"innovative":[120],"future":[124],"progress":[125],"field,":[128],"contribute":[131],"effective":[134],"immunotherapy":[138],"aligned":[139],"scope":[142],"regulatory":[144],"science.":[145],"covers":[148],"vaccines,":[150],"effector":[151],"therapy,":[153],"inhibition":[155],"immunosuppression,":[157],"including":[158],"inhibitors.":[161]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":6},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}